InvestorsHub Logo
Followers 12
Posts 1388
Boards Moderated 0
Alias Born 03/17/2005

Re: Drugdoctor post# 25904

Monday, 03/16/2015 9:36:48 PM

Monday, March 16, 2015 9:36:48 PM

Post# of 63806
Yea, I know all that. I have flipped this thing from the beginning. Pxyn has never performed up to its potential due to very poor management financial decisions. Now they are hiding massive dilution by a gagged TA. They have always had significant cash problems and I see no change in that in the near future.

The resent Form 5 states that they are issuing shares. This is the only visibility available.

Noone knows the impact of TPS dumping Pxyn. ("On December 31, 2014, Trestles Pain Specialists, LLC, a California limited liability company (“TPS”) delivered to the Company’s Board of Directors a notarized letter to cancel all of TPS’s 166,664 shares of Series D Convertible Preferred Stock.")